• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A

    Volume
    22
    Pagination
    48 - 49
    Journal
    HAEMOPHILIA
    ISSN
    1351-8216
    Metadata
    Show full item record
    Authors
    Nolan, B; Liesner, R; Young, G; Mahlangu, J; Pasi, KJ; Lethagen, S; Cristiano, LM; Yuan, H; Pierce, GF; Allen, G
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/15561
    Collections
    • Centre for Immunobiology [1014]
    Copyright statements
    © 2016 The Authors Haemophilia © 2016 John Wiley & Sons Ltd
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.